Vanguard Capital Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.9M Sell
919,849
-3,469
-0.4% -$122K ﹤0.01% 2128
2026
Q2
$29M Buy
923,318
+32,035
+4% +$1.35M ﹤0.01% 2240
2026
Q1
$49.3M Buy
+891,283
New +$42.4M ﹤0.01% 1856

Other funds holding PAHC

Vanguard Capital Management's PAHC Position: Q3 2026 in Review

Vanguard Capital Management reduced its Phibro Animal Health (PAHC) stake by 0.38% in Q3 2026, selling an estimated $122K and leaving 919,849 shares worth $32.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2128.

Vanguard Capital Management first reported a position in PAHC in Q1 2026 and has held it in 3 quarters since. The position peaked at $49.3M in Q1 2026. 236 funds tracked by Wall St. Rank hold PAHC as of Q3 2026.

  • Vanguard Capital Management held 919,849 shares of Phibro Animal Health worth $32.9M as of Q3 2026.
  • Vanguard Capital Management sold 3,469 Phibro Animal Health shares in Q3 2026, an estimated $122K.
  • Phibro Animal Health made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2128 holding.
  • Vanguard Capital Management first reported a position in Phibro Animal Health in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Phibro Animal Health position peaked at $49.3M in Q1 2026.
  • 236 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.